Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Acromegaly Treatment Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of genetic & hormonal diseases worldwide
5.1.1.2. Rising awareness regarding acromegaly diagnosis & treatment
5.1.1.3. Adoption of surgical procedures and radiation therapies for acromegaly treatment
5.1.2. Restraints
5.1.2.1. High cost of acromegaly treatment and incidences of drug recalls
5.1.3. Opportunities
5.1.3.1. Development of new acromegaly drug formulations and route of administration
5.1.3.2. Hormone therapy approvals for acromegaly treatments
5.1.4. Challenges
5.1.4.1. Side effects associated with drug treatments
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Acromegaly Treatment Market, by Disease Type
6.1. Introduction
6.2. Ectopic Acromegaly
6.3. Pseudo Acromegaly

7. Acromegaly Treatment Market, by Drug Class
7.1. Introduction
7.2. Bromocriptine Mesylate (Parlodel)
7.3. Dopamine Agonists
7.4. Growth Hormone Receptor Antagonist
7.5. Somatostatin Analogs (SSAs)
7.6. Somatuline Depot (Lanreotide)
7.7. Somavert (Pegvisomant)

8. Acromegaly Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Acromegaly Treatment Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Homecare Settings
9.4. Hospitals & Clinics

10. Americas Acromegaly Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Acromegaly Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Acromegaly Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. AbbVie Inc.
14.1.2. Advanz Pharma Services (UK) Limited
14.1.3. Aetna Inc.
14.1.4. Amolyt Pharma SAS
14.1.5. Amryt Pharma PLC
14.1.6. Bayer AG
14.1.7. Biodexa Pharmaceuticals PLC
14.1.8. Boehringer Ingelheim International GmbH
14.1.9. Bristol-Myers Squibb Company
14.1.10. Crinetics Pharmaceuticals, Inc.
14.1.11. DexTech Medical AB
14.1.12. Dr. Reddy’s Laboratories Ltd.
14.1.13. Eli Lilly and Company
14.1.14. Foresee Pharmaceuticals Co., Ltd.
14.1.15. Hikma Pharmaceuticals PLC
14.1.16. Ionis Pharmaceuticals, Inc.
14.1.17. Ipsen Pharma
14.1.18. Lupin Pharmaceuticals, Inc.
14.1.19. Merck & Co., Inc.
14.1.20. Mylan N.V.
14.1.21. Novartis AG
14.1.22. Peptron Inc.
14.1.23. Pfizer Inc.
14.1.24. Teva Pharmaceutical Industries Ltd.
14.1.25. Validus Pharmaceuticals LLC
14.1.26. Xeris Pharmaceuticals, Inc.
14.2. Key Product Portfolio

15. Appendix
15.1. Discussion Guide
15.2. License & Pricing



List of Figures

FIGURE 1. ACROMEGALY TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. ACROMEGALY TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. ACROMEGALY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ACROMEGALY TREATMENT MARKET DYNAMICS
FIGURE 7. ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 8. ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. ACROMEGALY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. ACROMEGALY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ACROMEGALY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. ACROMEGALY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ACROMEGALY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 6. ACROMEGALY TREATMENT MARKET SIZE, BY ECTOPIC ACROMEGALY, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ACROMEGALY TREATMENT MARKET SIZE, BY PSEUDO ACROMEGALY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 9. ACROMEGALY TREATMENT MARKET SIZE, BY BROMOCRIPTINE MESYLATE (PARLODEL), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ACROMEGALY TREATMENT MARKET SIZE, BY DOPAMINE AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ACROMEGALY TREATMENT MARKET SIZE, BY GROWTH HORMONE RECEPTOR ANTAGONIST, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ACROMEGALY TREATMENT MARKET SIZE, BY SOMATOSTATIN ANALOGS (SSAS), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ACROMEGALY TREATMENT MARKET SIZE, BY SOMATULINE DEPOT (LANREOTIDE), BY REGION, 2018-2030 (USD MILLION)
TABLE 14. ACROMEGALY TREATMENT MARKET SIZE, BY SOMAVERT (PEGVISOMANT), BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 16. ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ACROMEGALY TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. ACROMEGALY TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. ACROMEGALY TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. ACROMEGALY TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. ACROMEGALY TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 37. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. CANADA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 41. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. MEXICO ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ACROMEGALY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. CHINA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. CHINA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CHINA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. INDIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 63. INDIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. INDIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. INDIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. INDONESIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. JAPAN ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 71. JAPAN ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. JAPAN ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. JAPAN ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. MALAYSIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. PHILIPPINES ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. SINGAPORE ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. TAIWAN ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. THAILAND ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. THAILAND ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. THAILAND ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. THAILAND ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 107. DENMARK ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 108. DENMARK ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. DENMARK ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. EGYPT ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 112. EGYPT ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 113. EGYPT ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. EGYPT ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. FINLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. FINLAND ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 117. FINLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. FINLAND ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 133. ITALY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. ITALY ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. NORWAY ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 144. NORWAY ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 145. NORWAY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. NORWAY ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. POLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. POLAND ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 149. POLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. POLAND ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. QATAR ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. QATAR ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. QATAR ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. QATAR ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWEDEN ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 175. SWITZERLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. TURKEY ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 180. TURKEY ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 181. TURKEY ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. TURKEY ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM ACROMEGALY TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. ACROMEGALY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 192. ACROMEGALY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 193. ACROMEGALY TREATMENT MARKET LICENSE & PRICING